An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma

Leuk Lymphoma. 2018 Nov;59(11):2749-2751. doi: 10.1080/10428194.2018.1452217. Epub 2018 Mar 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Chemoradiotherapy
  • Hodgkin Disease / pathology
  • Hodgkin Disease / therapy*
  • Humans
  • Male
  • Nivolumab / metabolism
  • Nivolumab / therapeutic use*
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors*
  • Programmed Cell Death 1 Receptor / metabolism
  • Radiotherapy Dosage*
  • Treatment Outcome
  • Young Adult

Substances

  • Programmed Cell Death 1 Receptor
  • Nivolumab